Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform

Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform

Abstract Background Current drug regimens for cutaneous leishmaniasis (CL) include toxic systemic therapies such as amphotericin B (AB) and pentavalent antimonials. Fluconazole (FZ) is a well-tolerated potential oral alternative for the management CL. To date, few objective data exist to guide clini...

Full description

Bibliographic Details
Main Authors: Ruwandi Kariyawasam, Priyanka Challa, Rachel Lau, Andrea K. Boggild
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Infectious Diseases
Subjects:
Leishmania
Drug susceptibility
Sensititre™ YeastOne™ YO9
Amphotericin B
Fluconazole
Azole antifungals
Online Access:http://link.springer.com/article/10.1186/s12879-019-4237-3

Internet

http://link.springer.com/article/10.1186/s12879-019-4237-3

Similar Items